Cholesstrinol HP and HPe are improvements upon the company's Cholesstrinol heart health formula.
SourceOne Global Partners LLC (Chicago) says it has improved upon its Cholesstrinol heart health formula by more than doubling the potency of citrus polymethoxylated flavones (PMFs) and palm tocotrienols in the formula. The innovation yields two patented formulas: Cholesstrinol HP and Cholesstrinol HPe.
Several published studies support SourceOne’s branded PMF’s (PMF-Source) and tocotrienols (TocoSource) for reducing cholesterol and improving lipid profiles.
“Through our advanced extract and concentration technologies, we have super concentrated the standardized citrus flavonoid complexes found in Cholesstrinol beyond levels ever conceived,” says Rob Brewster, president of Ingredients by Nature (Montclair, CA), SourceOne’s citrus ingredients supplier. The higher concentration should allow for reduced capsule sizes and costs.
Ingredients by Nature also provides eriocitrin for Cholesstrinol HPe. Eriocitrin is a lemon-derived anti-inflammatory flavonoid that can reportedly suppress inflammation moreso than quercetin. Brewster says commercial quantities of high-purity eriocitrin were previous unavailable on the market.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.